This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Life Sciences - Transactions

As a key part of Kaye Scholer’s nationally recognized Life Sciences Practice, our Life Sciences Transactional team is specifically focused on representing pharmaceutical, biotechnology, medical device and other life sciences companies across the full spectrum of deal-making: from M&A through licensing and collaboration to financing. Our clients range from early-stage biotechs to major international pharmaceutical companies.

In the Market

Capabilities: How We Do It

  • Mergers & Acquisitions: We represent buyers and sellers on mergers, acquisitions and other business combinations. Our industry experience can be particularly helpful in deal structuring and due diligence, as we are highly attuned to intellectual property, commercial relationships, and industry dynamics that are key to these transactions.

  • Licenses and Collaborations: We advise and negotiate licensing, collaboration and other commercial arrangements throughout a product’s life cycle:

    • Research Stage
      • Research collaborations and license agreements
      • University licenses and sponsored research agreements
      • Option agreements
      • Pre-clinical research agreements
      • Material transfer agreements (MTA’s)
    • Development Stage
      • Licenses and co-development collaborations
      • Clinical research agreements
      • Contract research organization (CRO) agreements
    • Commercialization Stage
      • Co-promotion/co-development alliances
      • Marketing and distribution agreements
      • Product acquisitions and divestitures
      • Manufacturing and supply agreements
      • Contract sales organization (CSO) agreements
  • Financing: We advise both life science companies and their investors on a full range of financing matters. Our investor clients include private equity funds, venture capital funds and mature life sciences companies investing in early-stage companies. We are experienced in financing transactions that involve control and minority investments, “club deals” and co-investments, and all stages of the investment cycle across the variety of transaction structures. Our financing experience includes:

    • Venture capital financing for early stage companies,
    • Initial public offerings
    • PIPE (private investment in public entity) transactions.
  • Legal Skills Backed by Solid Science: Our team’s scientific advisers hold advanced and terminal degrees in molecular biology, chemistry, biochemistry and medicine, among other fields, providing our lawyers guidance and understanding of the science behind the business.